Today: 16 May 2026
Silver Price Today Falls More Than 3% as Oil Surge and Stronger Dollar Hit Bullion (Reuters)
26 March 2026
2 mins read

Silver Price Today Falls More Than 3% as Oil Surge and Stronger Dollar Hit Bullion (Reuters)

NEW YORK, March 26, 2026, 13:23 (EDT)

Silver sank more than 3% Thursday, giving back a chunk of the previous day’s surge. A stronger dollar, plus another lift in oil, stoked fresh inflation fears and sent traders heading for the exits on bullion. By 11:15 a.m. ET, spot silver had dropped 3.2% to $68.97 an ounce.

Silver’s behavior is shifting—it’s not acting like the usual safe harbor these days, but instead is moving more in line with assets that react to rate swings. Brent crude pushed up past $105 per barrel again, and the dollar firmed. “Markets are being driven by oil prices,” said Peter Cardillo at Spartan Capital Securities. It’s a tough backdrop for bullion, which offers no yield. Reuters

The shift showed up just a day before. Spot silver jumped 1.7% on Wednesday to $72.41, with oil sliding and traders positioning for lower inflation possibly opening the door to Fed rate cuts before year-end.

After Thursday’s drop, silver sits over 40% under the all-time high of $117.69 an ounce hit on Jan. 26, despite its sharp rally earlier this year. Volatility has outpaced gold, with silver’s fortunes tied to both investment trends and industrial usage.

Jim Wyckoff, senior analyst at Kitco Metals, pointed to higher rates and inflation as factors dragging bullion lower. A drawn-out conflict, he said, could push prices down further. But if a ceasefire materializes, rate-cut expectations might resurface.

Peter Grant, vice president and senior metals strategist at Zaner Metals, flagged on Wednesday that slipping oil prices contributed to a “technical recovery,” but said markets still wanted to see more cooling in inflation fears before giving real weight to another U.S. rate cut. That view didn’t last long—Thursday’s action quickly tore up that playbook. Reuters

Silver wasn’t the only casualty. Spot gold slid 1.1% to $4,455.51 an ounce; platinum dropped 3.2%, settling at $1,858.46, and palladium tumbled 4.5% to $1,359.62. Pressure hit the entire precious-metals group.

Traders kept their focus on rates after U.S. data offered few surprises. Initial jobless claims ticked up 5,000 to 210,000 last week. Continuing claims dropped to 1.819 million—marking the lowest level since May 2024. The numbers underscore a labor market that hasn’t softened, giving the Fed room to stay wary as energy-fueled inflation risks linger.

The rates debate isn’t over. Reuters’ economist poll still points to a Fed cut by September—at least one this year—even as traders have erased bets on easing stretching into 2026. Jonathan Millar over at Barclays calls it “entirely plausible” for the Fed to simply ride out the oil shock. If crude prices settle or ceasefire talks start to stick, silver could bounce again. But if the conflict drags out and inflation broadens, the metal looks vulnerable. Reuters

The Silver Institute, in a February update, projected the market was on track for its sixth annual deficit in 2026. Still, it expects industrial fabrication to dip 2% as solar makers cut silver use. Demand from data centers, AI tech, and autos is set to partially cushion that drop.

Stock Market Today

  • PVH Shares Drop 3% as April Inflation Surges to 3.8% Annual Rate
    May 15, 2026, 8:16 PM EDT. PVH shares fell 3% following the latest Consumer Price Index report showing inflation at a 3.8% annual rate in April, the fastest since 2023. Energy costs, notably a 5.4% rise in gasoline prices linked to the Iran conflict, sharply increased. Higher prices for essentials like food and shelter raised concerns over reduced consumer spending on discretionary items, impacting retail and consumer goods sectors. PVH's stock, volatile with 14 moves over 5% in the past year, reacted moderately compared to a recent 7.7% drop amid crude oil price surges and weak consumer sentiment. Goldman Sachs lowered its 2026 discretionary cash flow forecast from 5.1% to 3.7%, citing squeezed consumer budgets. PVH trades 18% below its 52-week high, with long-term investors facing a decline in value.

Latest articles

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
US Stock Market Today: Dow Jones, S&P 500 and Nasdaq Slide as Oil Tops $105 and Fed Cut Hopes Fade
Previous Story

US Stock Market Today: Dow Jones, S&P 500 and Nasdaq Slide as Oil Tops $105 and Fed Cut Hopes Fade

Crypto Stocks to Watch Today: MARA Bucks Selloff as Bitfarms, HIVE, CleanSpark, Riot, Bitdeer and Galaxy Stay in Focus
Next Story

Crypto Stocks to Watch Today: MARA Bucks Selloff as Bitfarms, HIVE, CleanSpark, Riot, Bitdeer and Galaxy Stay in Focus

Go toTop